DK1534352T3 - Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme - Google Patents

Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme

Info

Publication number
DK1534352T3
DK1534352T3 DK03762631T DK03762631T DK1534352T3 DK 1534352 T3 DK1534352 T3 DK 1534352T3 DK 03762631 T DK03762631 T DK 03762631T DK 03762631 T DK03762631 T DK 03762631T DK 1534352 T3 DK1534352 T3 DK 1534352T3
Authority
DK
Denmark
Prior art keywords
implant
same
pharmacologically active
transporting
preparing
Prior art date
Application number
DK03762631T
Other languages
English (en)
Inventor
Roman Denk
Original Assignee
Celonova Biosciences Germany G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celonova Biosciences Germany G filed Critical Celonova Biosciences Germany G
Application granted granted Critical
Publication of DK1534352T3 publication Critical patent/DK1534352T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Steroid Compounds (AREA)
DK03762631T 2002-07-05 2003-07-04 Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme DK1534352T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10230190 2002-07-05
PCT/EP2003/007197 WO2004004795A1 (en) 2002-07-05 2003-07-04 Implant for transport and release for pharmacologically active agents as well as a process for producing the same

Publications (1)

Publication Number Publication Date
DK1534352T3 true DK1534352T3 (da) 2008-12-15

Family

ID=30009809

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03762631T DK1534352T3 (da) 2002-07-05 2003-07-04 Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme

Country Status (13)

Country Link
EP (1) EP1534352B1 (da)
JP (1) JP2005532101A (da)
CN (1) CN1304062C (da)
AT (1) ATE407710T1 (da)
AU (2) AU2003246387A1 (da)
BR (1) BR0312453A (da)
CA (1) CA2491282C (da)
DE (1) DE60323510D1 (da)
DK (1) DK1534352T3 (da)
ES (1) ES2311733T3 (da)
PT (1) PT1534352E (da)
SI (1) SI1534352T1 (da)
WO (1) WO2004004795A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1432380T3 (da) 2001-08-17 2007-01-15 Polyzenix Gmbh Indretning baseret på nitrol med et overtræk af polyphosphazen
EP1605983B1 (en) * 2003-03-26 2011-01-05 CeloNova BioSciences Germany GmbH Coated dental implants
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
JP4885866B2 (ja) * 2004-10-25 2012-02-29 セロノヴァ バイオサイエンスィズ ジャーマニー ゲーエムベーハー 治療適用および／または診断適用のための充填可能なポリホスファゼン含有粒子、ならびにその調製方法および使用方法
JP2010533505A (ja) * 2006-10-10 2010-10-28 セロノバ バイオサイエンシーズ， インコーポレイテッド シリコーンおよび特定のポリホスファゼンを含む組成物およびデバイス
US8883190B2 (en) * 2006-12-01 2014-11-11 Wake Forest University Health Sciences Urologic devices incorporating collagen inhibitors
WO2009054851A1 (en) * 2007-10-24 2009-04-30 Celonova Biosciences, Inc. Specific polyphosphazene-containing three-dimensional bone support implants and mehods for their use
WO2009058145A1 (en) * 2007-10-31 2009-05-07 Celonova Biosciences, Inc. Vasodilator eluting luminal stent devices with a specific polyphosphazene coating and methods for their manufacture and use
WO2009058146A1 (en) * 2007-10-31 2009-05-07 Celonova Bioscience, Inc. Vasodilator eluting blood storage and administration devices with a specific polyphosphazene coating and methods for their manufacture and use
WO2009058147A1 (en) * 2007-10-31 2009-05-07 Celonova Biosciences, Inc. Loadable polymeric particles for therapeutic use in erectile dysfunction
CN102176868A (zh) * 2008-02-11 2011-09-07 西洛诺瓦生物科学公司 组织紧固物品和装置以及相关方法
EP2254605A4 (en) * 2008-02-22 2012-06-20 Celonova Biosciences Inc MULTIFUNCTIONAL WOUND BRACING MATRICES AND RELEVANT PROCEDURES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1475611A1 (ru) * 1987-06-10 1989-04-30 Предприятие П/Я А-3697 Устройство дл соединени трубчатых органов
US4975280A (en) * 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
US6224626B1 (en) * 1998-02-17 2001-05-01 Md3, Inc. Ultra-thin expandable stent
CN1211130C (zh) * 2000-03-18 2005-07-20 保利詹尼克斯有限公司 具有抗菌性的聚磷腈衍生物及其应用
EP1274471B1 (de) * 2000-04-11 2007-01-03 Polyzenix GmbH Verwendung von Folien aus Poly-Tri-Fluor-Ethoxypolyphosphazenen zur Umhüllung von medizinischen Vorrichtungen
EP1179353A1 (de) * 2000-08-11 2002-02-13 B. Braun Melsungen Ag Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
DE50110900D1 (de) * 2000-11-21 2006-10-12 Schering Ag Röhrenförmige gefässimplantate (stents) sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
ATE407710T1 (de) 2008-09-15
CN1304062C (zh) 2007-03-14
SI1534352T1 (sl) 2009-02-28
EP1534352B1 (en) 2008-09-10
BR0312453A (pt) 2005-04-19
CA2491282C (en) 2013-02-12
EP1534352A1 (en) 2005-06-01
ES2311733T3 (es) 2009-02-16
DE60323510D1 (de) 2008-10-23
HK1080764A1 (en) 2006-05-04
CN1665550A (zh) 2005-09-07
AU2010202360B2 (en) 2012-06-28
PT1534352E (pt) 2008-11-13
JP2005532101A (ja) 2005-10-27
AU2003246387A1 (en) 2004-01-23
CA2491282A1 (en) 2004-01-15
AU2010202360A1 (en) 2010-07-01
WO2004004795A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
NO20085077L (no) Nye forbindelser
AR028833A1 (es) Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion
NO20026064D0 (no) Nye forbindelser
NO20023934D0 (no) Nye forbindelser
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
BR0007589A (pt) Inibidores da proliferação de células
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
ATE316083T1 (de) Adamantanderivate
ATE386725T1 (de) Heterocyclylverbindungen
HRP20050830A2 (en) Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
SI1534352T1 (sl) Vsadek za transport in sproščanje farmakoloških učinkovin, kot tudi postopek za proizvodnjo le-tega
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
SE0101038D0 (sv) Novel compounds
DE60215313D1 (de) Indolderivate und deren verwendung als gnrh antagonisten
SE0003476D0 (sv) Compounds
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE341319T1 (de) Esmolol-enthaltende zubereitungen
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20026081L (no) Nye forbindelser
BR0315620A (pt) Derivados de n-benzodioxolil, n-benzodioxanil e n-benzodioxepinil arilcarboxamida, e composições farmacêuticas compreendendo os mesmos
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
EA200501433A1 (ru) Система подкожной доставки, способ ее получения и ее применение для лечения холинергических дефицитных расстройств